RE:When should we expect the remaining IPF results ? The impression I got from Analyst Day was that the IPF results for the full 40 patients will be reported on sometime in February, probably late February. The results should catalyze partnership discussions especially with Roche if the data show that 4050 in combination with pirfenidone is significantly better than 4050 alone and 4050 in combination with nintedanib (as the animal studies indicate). I would hope that an IPF partnership deal could be struck before the start of the upcoming pivotal trials. With regional partnership deals in Asia, a major partnership deal on IPF and the start of Pg commercial production, PLI should rapidly shift into the next stage of commercial development and put a big smile on the face of all its shareholders.